CN1240707C - 2－卤代－6－0－取代的酮内酯衍生物 - Google Patents

2－卤代－6－0－取代的酮内酯衍生物 Download PDF

Info

Publication number
CN1240707C
CN1240707C CNB988127326A CN98812732A CN1240707C CN 1240707 C CN1240707 C CN 1240707C CN B988127326 A CNB988127326 A CN B988127326A CN 98812732 A CN98812732 A CN 98812732A CN 1240707 C CN1240707 C CN 1240707C
Authority
CN
China
Prior art keywords
compound
formula
aryl
heteroaryl
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB988127326A
Other languages
English (en)
Chinese (zh)
Other versions
CN1283199A (zh
Inventor
T·范利
Y·S·沃尔
D·T·楚
J·J·普拉特纳
陈燕
R·F·克拉克
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Publication of CN1283199A publication Critical patent/CN1283199A/zh
Application granted granted Critical
Publication of CN1240707C publication Critical patent/CN1240707C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Cephalosporin Compounds (AREA)
CNB988127326A 1997-10-29 1998-10-29 2－卤代－6－0－取代的酮内酯衍生物 Expired - Fee Related CN1240707C (zh)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US95988197A 1997-10-29 1997-10-29
US08/959,881 1997-10-29
US08/959881 1997-10-29
US15423998A 1998-09-16 1998-09-16
US09/154239 1998-09-16
US09/154,239 1998-09-16

Publications (2)

Publication Number Publication Date
CN1283199A CN1283199A (zh) 2001-02-07
CN1240707C true CN1240707C (zh) 2006-02-08

Family

ID=26851273

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB988127326A Expired - Fee Related CN1240707C (zh) 1997-10-29 1998-10-29 2－卤代－6－0－取代的酮内酯衍生物

Country Status (24)

Country Link
EP (1) EP1027362B1 (enExample)
JP (1) JP2001521039A (enExample)
KR (1) KR100536420B1 (enExample)
CN (1) CN1240707C (enExample)
AR (1) AR015994A1 (enExample)
AT (1) ATE298760T1 (enExample)
AU (1) AU751448B2 (enExample)
BG (1) BG64707B1 (enExample)
BR (1) BR9813319A (enExample)
CA (1) CA2307788C (enExample)
CO (1) CO4990960A1 (enExample)
CZ (1) CZ300063B6 (enExample)
DE (1) DE69830739T2 (enExample)
DK (1) DK1027362T3 (enExample)
ES (1) ES2244094T3 (enExample)
HU (1) HUP0004282A3 (enExample)
IL (1) IL135519A0 (enExample)
NO (1) NO20002190L (enExample)
NZ (1) NZ503822A (enExample)
PL (1) PL191453B1 (enExample)
PT (1) PT1027362E (enExample)
SK (1) SK286397B6 (enExample)
TR (1) TR200001142T2 (enExample)
WO (1) WO1999021871A1 (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE39743E1 (en) * 1998-10-15 2007-07-24 Aventis Pharma S.A. 2-halogenated derivatives of 5-0 desosaminyl-erythronolide a, their preparation process and their antibiotic use
FR2784682B1 (fr) * 1998-10-15 2002-12-06 Hoechst Marion Roussel Inc Nouveaux derives 2-halogene de 5-0-desosaminylerythronolide a, leur procede de preparation et leur application comme medicaments
NZ515027A (en) 1999-04-16 2004-01-30 Kosan Biosciences Inc Erythromycin derivatives as antibiotics
US6514944B2 (en) 1999-04-16 2003-02-04 Kosan Biosciences, Inc. Macrolide antiinfective agents
US6939861B2 (en) 1999-04-16 2005-09-06 Kosan Biosciences, Inc. Amido macrolides
US6451768B1 (en) 1999-04-16 2002-09-17 Kosan Biosciences, Inc. Macrolide antiinfective agents
US6569836B2 (en) 1999-12-02 2003-05-27 Abbott Laboratories 6-O-alkyl-2-nor-2-substituted ketolide derivatives
JP2003527347A (ja) * 1999-12-02 2003-09-16 アボット・ラボラトリーズ ６−ｏ−アルキル−２−ノル−２−置換ケトリド誘導体
JP2001261694A (ja) * 2000-03-06 2001-09-26 Pfizer Prod Inc ケトライド抗生物質
US6605707B1 (en) 2000-03-23 2003-08-12 Abbott Laboratories Process for the preparation of 6-O-propargyl erythromycin derivatives
PT1167376E (pt) 2000-06-30 2004-09-30 Pfizer Prod Inc Antibioticos macrolidos
US6472372B1 (en) * 2000-12-06 2002-10-29 Ortho-Mcneil Pharmaceuticals, Inc. 6-O-Carbamoyl ketolide antibacterials
CA2460947A1 (en) 2001-09-17 2003-03-27 Ortho-Mcneil Pharmaceutical, Inc. 6-o-carbamate-11,12-lacto-ketolide antimicrobials
RU2004117082A (ru) 2001-12-05 2005-04-10 Орто-Макнейл Фармасьютикал, Инк. (Us) Кетолидные 6-0-ацил-производные эритромицина в качестве антибактериальных средств
WO2003068790A2 (en) * 2002-02-13 2003-08-21 Abbott Laboratories Macrolide antibacterial compounds
CA2483220A1 (en) * 2002-04-25 2003-11-06 Abbott Laboratories Oxolide antibacterials
WO2003090761A1 (en) * 2002-04-25 2003-11-06 Abbott Laboratories 9-oxime macrolide antibacterials
WO2004078771A1 (ja) * 2003-03-07 2004-09-16 Taisho Pharmaceutical Co., Ltd. ２－フルオロ－６－ｏ－置換ケトライド誘導体
JP2007254285A (ja) * 2004-03-16 2007-10-04 Taisho Pharmaceut Co Ltd ２−フルオロ−６−ｏ−置換ケトライド誘導体
MX2011012614A (es) * 2009-05-27 2012-02-22 Wockhardt Ltd Compuestos de quetolida que tienen actividad antimicrobiana.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8506380D0 (en) * 1985-03-12 1985-04-11 Beecham Group Plc Chemical compounds
IL99995A (en) * 1990-11-21 1997-11-20 Roussel Uclaf Erythromycin derivatives, their preparation and pharmaceutical compositions containing them
WO1993021199A1 (fr) * 1992-04-22 1993-10-28 Taisho Pharmaceutical Co., Ltd. Derive de 5-o-desosaminylerythronolide
FR2742757B1 (fr) * 1995-12-22 1998-01-30 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments

Also Published As

Publication number Publication date
KR20010015793A (ko) 2001-02-26
CN1283199A (zh) 2001-02-07
DE69830739T2 (de) 2006-04-20
EP1027362B1 (en) 2005-06-29
PL191453B1 (pl) 2006-05-31
DK1027362T3 (da) 2005-10-31
CA2307788C (en) 2008-05-20
ATE298760T1 (de) 2005-07-15
PL340290A1 (en) 2001-01-29
SK6332000A3 (en) 2000-09-12
HK1031383A1 (en) 2001-06-15
HUP0004282A3 (en) 2001-10-29
AU751448B2 (en) 2002-08-15
ES2244094T3 (es) 2005-12-01
DE69830739D1 (de) 2005-08-04
NZ503822A (en) 2002-12-20
SK286397B6 (sk) 2008-09-05
CO4990960A1 (es) 2000-12-26
CZ20001525A3 (cs) 2000-10-11
PT1027362E (pt) 2005-08-31
BG64707B1 (bg) 2005-12-30
EP1027362A1 (en) 2000-08-16
AU1288199A (en) 1999-05-17
CZ300063B6 (cs) 2009-01-21
KR100536420B1 (ko) 2005-12-16
NO20002190D0 (no) 2000-04-27
WO1999021871A1 (en) 1999-05-06
IL135519A0 (en) 2001-05-20
BR9813319A (pt) 2000-08-22
BG104434A (en) 2001-01-31
AR015994A1 (es) 2001-05-30
HUP0004282A2 (hu) 2001-04-28
TR200001142T2 (tr) 2000-09-21
JP2001521039A (ja) 2001-11-06
CA2307788A1 (en) 1999-05-06
NO20002190L (no) 2000-06-29

Similar Documents

Publication Publication Date Title
CN1240707C (zh) 2－卤代－6－0－取代的酮内酯衍生物
CN1273475C (zh) 具有抗细菌活性的6－0－取代的酮基内酯类化合物
CN1310934C (zh) 可用作抗菌剂的红霉素6－o－氨基甲酰基酮内酯衍生物
CN1244202A (zh) 三环红霉素衍生物
CN1241931C (zh) 大环内酯抗感染药物
CN1216064C (zh) 6－o－取代的红霉素衍生物的制备方法
CN100335491C (zh) 具有抗炎活性的大环内酯化合物
CN1052984C (zh) 新的红霉素衍生物、其制备方法及其作为药物的应用
CN1659178A (zh) 6、11二环红霉素衍生物
CN1271363A (zh) 具有抗菌活性的3’－n－修饰的6－o－取代的红霉素酮基内酯衍生物
CN1343215A (zh) 具有抗菌活性的6－o－取代大环内酯类化合物
CN1612888A (zh) 大环内酯类化合物
CN1278266A (zh) 6,11－桥连红霉素衍生物
CN1259135A (zh) 9－肟红霉素衍生物
CN1151165C (zh) 具有抗炎活性的大环内酯
CN1633444A (zh) 6－11双环酮大环内酯衍生物
CN1202116C (zh) 除虫菌素衍生物
CN1215403A (zh) 头孢烯化合物及含该化合物的医药
CN1630661A (zh) 具有抗菌活性的大环内酯类化合物
CN1589277A (zh) 6－o－氨基甲酸酯－11,12－内酯－酮内酯抗菌剂
CN1780846A (zh) 双官能杂环化合物及其制备和使用方法
CN1585775A (zh) 可用作抗菌药的红霉素的6－o－酰基酮内酯衍生物
CN1729200A (zh) 大环内酯类
CN1040877C (zh) 红霉素的新衍生物、它们的制备方法和作为药物的应用
CN1307584A (zh) 大环内酯lhrh拮抗剂

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C56 Change in the name or address of the patentee

Owner name: ABBOTT PHARMACEUTICAL CO., LTD.

Free format text: FORMER NAME: ABBOTT LAB

CP01 Change in the name or title of a patent holder

Address after: Illinois State

Patentee after: ABBOTT LABORATORIES

Address before: Illinois State

Patentee before: ABBOTT LABORATORIES

C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20060208

Termination date: 20101029